Search results
EC approves Takeda’s Fruzaqla for metastatic colorectal cancer
Pharmaceutical Technology via Yahoo Finance· 1 day agoFor the first time in over a decade, patients with previously treated metastatic colorectal cancer...
FDA Approves Bristol Myers Squibb's Combination Therapy For Colorectal Cancer Patients With Certain...
Benzinga via Yahoo Finance· 22 hours agoFriday, the FDA granted accelerated approval to Bristol Myers Squibb & Co’s (NYSE:BMY) Krazati...
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
Zacks via Yahoo Finance· 16 hours agoBristol Myers (BMY) wins FDA approval for Krazati, in combination with Erbitux, as a targeted ...
New immunotherapy shows promise for advanced colorectal cancer in early trial
MedicalNewsToday via AOL· 5 days agoA combination of two monoclonal antibodies was effective in 61% of people with the most common form...
BMS expands Krazati’s FDA label to include colorectal cancer
Pharmaceutical Technology via Yahoo Finance· 18 hours agoThe US Food and Drug Administration (FDA) has approved Bristol Myers Squibb's (BMS) Krazati...
Aspirin Use Enhances Immunosurveillance in Colorectal Cancer
Medscape· 4 days agoProf David Kerr discusses recent study results related to the impact of aspirin on the tumor...
RTP drugmaker plans 'headcount reductions' after failing late-stage trial - Triangle Business...
The Business Journals· 14 hours agoA biopharmaceutical company in Research Triangle Park has failed to hit its target in a pivotal,...
Timing of Chemo Could Be Key to Pancreatic Cancer Outcomes | Fox 11 Tri Cities Fox 41 Yakima
FOX 11/41 Yakima· 1 day agoGiving people with pancreatic cancer chemotherapy both before and after a tumor-removing surgery...
GenFleet receives China NMPA approval for Phase I/II solid tumour trial
Clinical Trials Arena via Yahoo Finance· 5 days agoIn April, the US Food and Drug Administration granted approval for GenFleet to commence a Phase III...
FDA Approves Adagrasib for KRAS G12C–Mutated CRC
Medscape· 4 days agoThis marks the first approval for a KRAS inhibitor to treat CRC.